Table 2.3.
1. Testing should be considered in adults with overweight or obesity (BMI ≥25 kg/m2 or ≥23 kg/m2 in Asian American individuals) who have one or more of the following risk factors: |
• First-degree relative with diabetes |
• High-risk race/ethnicity (e.g., African American, Latino, Native American, Asian American, Pacific Islander) |
• History of CVD |
• Hypertension (≥130/80 mmHg or on therapy for hypertension) |
• HDL cholesterol level <35 mg/dL (0.90 mmol/L) and/or a triglyceride level >250 mg/dL (2.82 mmol/L) |
• Individuals with polycystic ovary syndrome |
• Physical inactivity |
• Other clinical conditions associated with insulin resistance (e.g., severe obesity, acanthosis nigricans) |
2. People with prediabetes (A1C ≥5.7% [39 mmol/mol], IGT, or IFG) should be tested yearly. |
3. People who were diagnosed with GDM should have lifelong testing at least every 3 years. |
4. For all other people, testing should begin at age 35 years. |
5. If results are normal, testing should be repeated at a minimum of 3-year intervals, with consideration of more frequent testing depending on initial results and risk status. |
6. People with HIV |
CVD, cardiovascular disease; GDM, gestational diabetes mellitus; IFG, impaired fasting glucose; IGT, impaired glucose tolerance.